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Abstract: OBJECTIVE Hippocampal sclerosis (HS) is the most common cause of drug-resistant temporal
lobe epilepsy, and its accurate detection is important to guide epilepsy surgery. Radiological features of
HS include hippocampal volume loss and increased T2 signal, which can both be quantified to help im-
prove detection. In this work, we extend these quantitative methods to generate cross-sectional area and
T2 profiles along the hippocampal long axis to improve the localization of hippocampal abnormalities.
METHODS T1-weighted and T2 relaxometry data from 69 HS patients (32 left, 32 right, 5 bilateral)
and 111 healthy controls were acquired on a 3-T magnetic resonance imaging (MRI) scanner. Automated
hippocampal segmentation and T2 relaxometry were performed and used to calculate whole-hippocampal
volumes and to estimate quantitative T2 (qT2) values. By generating a group template from the con-
trols, and aligning this so that the hippocampal long axes were along the anterior-posterior axis, we
were able to calculate hippocampal cross-sectional area and qT2 by a slicewise method to localize any
volume loss or T2 hyperintensity. Individual patient profiles were compared with normative data gen-
erated from the healthy controls. RESULTS Profiling of hippocampal volumetric and qT2 data could
be performed automatically and reproducibly. HS patients commonly showed widespread decreases in
volume and increases in T2 along the length of the affected hippocampus, and focal changes may also be
identified. Patterns of atrophy and T2 increase in the left hippocampus were similar between left, right,
and bilateral HS. These profiles have potential to distinguish between sclerosis affecting volume and qT2
in the whole or parts of the hippocampus, and may aid the radiological diagnosis in uncertain cases or
cases with subtle or focal abnormalities where standard whole-hippocampal measurements yield normal
values. SIGNIFICANCE Hippocampal profiling of volumetry and qT2 values can help spatially localize
hippocampal MRI abnormalities and work toward improved sensitivity of subtle focal lesions.
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Abstract (289/300 words) 
Objective: Hippocampal sclerosis (HS) is the most common cause of drug-resistant temporal 
lobe epilepsy, and its accurate detection is important to guide epilepsy surgery. Radiological 
features of HS include hippocampal volume loss and increased T2 signal, which can both be 
quantified to help improve detection. In this work, we extend these quantitative methods to 
generate cross-sectional area and T2 profiles along the hippocampal long axis to improve the 
localisation of hippocampal abnormalities. 
Methods: T1-weighted and T2 relaxometry data of 69 HS patients (32 left, 32 right, 5 bilateral) 
and 111 healthy controls were acquired on a 3T MRI scanner. Automated hippocampal 
segmentation and T2 relaxometry were performed and used to calculate whole-hippocampal 
volumes and estimated quantitative T2 (qT2) values. By generating a group template from 
the controls, and aligning this so that the hippocampal long axes were along the anterior-
posterior axis, we were able to calculate hippocampal cross-sectional area and qT2 in a slice-
wise method to localise any volume loss or T2 hyperintensity. Individual patients were 
compared with normative data generated from the healthy controls. Twenty controls were 
rescanned for repeatability estimates. 
Results: Profiling of hippocampal volumetric and qT2 data could be performed automatically 
and reproducibly. HS patients generally showed widespread decreases in volume and 
increases in T2 along the length of the affected hippocampus. Patterns of atrophy and T2 
increase in the left hippocampus were similar between left HS and bilateral HS, and similarly 
for the right hippocampus between right HS and bilateral HS. These profiles have potential to 
distinguish between sclerosis affecting volume and qT2 in the whole or parts of the 
hippocampus. 
Significance: Hippocampal profiling of volumetry and qT2 values can help spatially localise 




- Hippocampal sclerosis (HS) is radiologically characterised by atrophy and increased 
T2-weighted signal 
- Quantification of these features improves sensitivity but utility may be limited if only 
providing one value for the whole hippocampus 
- Localised quantification through profiling along the anterior-posterior hippocampal 
axis can be automated reliably and reproducibly 
- This hippocampal profiling can be used as an additional tool towards improved 
characterisation, and possibly diagnosis, of HS 
 
Introduction 
Hippocampal sclerosis (HS) is the most common cause of medically refractory temporal lobe 
epilepsy (TLE) (Blumcke 2009), and surgical resection has a high chance of achieving seizure 
freedom (Wiebe 2001, De Tisi 2011). HS typically manifests radiologically as loss of volume, 
loss of internal architecture, and T2-hyperintensity (Van Paesschen 2004). MRI protocols used 
to visualise HS include high-resolution T1-weighted imaging to detect volume loss (atrophy) 
and T2-weighted or T2-FLAIR scans showing the latter two hallmarks (Jackson 1993a). Atrophy 
has been shown to correlate with seizure onset laterality (Bernasconi 2003) and seizure 
outcome after anterior temporal lobe resection (ATLR) (Schramm&Clusmann 2008). T2 
abnormalities can be present even if there is no hippocampal volume reduction, and have 
been reported as the most consistent MRI finding in HS (Meiners 1994). 
 
Quantitative evaluation of atrophy and T2 hyperintensities, using hippocampal volumetry and 
T2 relaxometry, can yield a higher sensitivity to detect HS than qualitative visual inspection 
(Jackson 1993a, Watson 1997, Coan 2014). Volumetry can help distinguish between normal 
and abnormal volumes in cases that may be difficult to classify visually (Jackson 1993b). T2 
relaxometry, also called quantitative T2 (qT2)measurements, can be used to give an objective 
reflection of the T2 relaxation properties of the tissue. 
 
In recent years, both volumetry (Winston 2013) and T2 relaxometry (Winston 2017) methods 
have been automated, enabling routine clinical use in comparing a patient’s individual values 
to a normative database of healthy control subjects. These methods, however, only yield a 
single volume and qT2 value per hippocampus and may be insensitive to subtle focal 
abnormalities (Woermann 1998). In this work, we present an automated method to generate 
subject-specific localised volume and qT2 profiles along the hippocampal long axis to 
overcome this limitation. The software is made freely available as an extension of the online 





Subjects underwent imaging on a 3T GE Discovery MR750 scanner with a 32-channel coil. 
Sequences included a three-dimensional (3D) T1-weighted inversion-recovery fast spoiled 
gradient recalled echo (TE/TR/TI 3.1/7.4/400 ms, field of view (FOV) 224×256×256 mm, matrix 
224×256×256, parallel imaging acceleration factor 2) and a coronal dual-echo fast recovery 
fast spin echo proton-density/T2-weighted (TE 30/119 ms, TR 7600 ms, FOV 220×220 mm, 
matrix 512×512, slice thickness 4 mm, SENSE factor 2). 
For patients, this was part of their routine clinical MRI protocol which also included a 3D T2-
FLAIR (as in Vos et al., 2018) which was presented to radiologists for reporting. 
 
Subjects 
We expanded our healthy controls group with respect to Winston et al. (Winston 2017) to 
111 healthy controls (age μ±σ 40.0±12.8, range 17.0-66.6 years; 52M/59F) without any 
history of neurologic or psychiatric disease, from previously scanned subjects. The study was 
considered a service improvement using clinically acquired data by the National Hospital for 
Neurology and Neurosurgery and the Institute of Neurology Joint Research Ethics Committee. 
Informed written consent was obtained from control subjects. 
 
We included 69 patients (age μ±σ 42.7±14.7, range 18.0-76 years; 31M/38F) who had 
undergone brain MRI with an epilepsy protocol as part of routine clinical practice for TLE at 
the Epilepsy Society MRI Unit, Chalfont St Peter, and which been reported by a 
neuroradiologist as showing unilateral or bilateral HS on visual assessment and concordant 
with neurological examination. This consisted of 32 left HS (LHS), 32 right HS (RHS), and five 
bilateral HS (BHS). 
 
Further, we reviewed all cases having undergone temporal lobe epilepsy surgery in our centre 
who had pathologically confirmed HS but without mention of HS in the radiological report. 
From those who had all sequences mentioned above, this yielded five subjects (see 
Supplementary Table S1 for details) 
 
Image processing 
Automated volumetry and T2 relaxometry was performed as described previous in Winston 
et al., 2013 and 2017, respectively. In brief, this used a multi-atlas-based algorithm for the 
segmentation (STEPS; Cardoso 2013) using the 3D-T1 images, which was then coregistered to 
the PD/T2 scan and used as a mask to obtain qT2 values in. Hippocampal volumes were 
corrected for total intracranial volume (TIV) as in Winston et al. (Winston 2013). 
 
The processing to obtain profiles along the anterior-posterior (AP) axis of the hippocampus 
then consists of 1) the generation of a group template; 2) registration of individual scans; 3) 
creating a normative database; 4) creating disease group average; and 5) comparing 
individual subject scans to that normative database. 
 
1) Group template generation 
The hippocampal regions of interest (ROIs) from the Harvard-Oxford atlas of the MNI-152 
template were extracted, and using principal component analysis, their long axis was 
obtained. The MNI-152 template was then reoriented so that the hippocampal ROIs were 
along the AP axis (Figure 1a). The 3D-T1 scans of all 111 healthy controls were then registered 
to this rotated MNI template in an iterative manner using ten affine registration steps and 
ten nonlinear (fast free-form deformation) registration steps to obtain a population-specific 
group average template. All registrations were done in the open-source NiftyReg software 
package (Figure 1b) (Modat 2010, Modat 2014). For use in the later steps, a distance-map 
along the AP axis of this template was generated (Figure 1c), from the most posterior slice to 
the most anterior slice (distances 1-218 mm, respectively). The hippocampal segmentations 
from the healthy controls were transformed to the group template with the obtained 
transformation parameters. Voxels were included in the group-wise hippocampal masks 
when they were included in at least half the individual segmentations. 
 
2) Registration of individual scan to template 
Each subject’s 3D-T1 scan was registered to the group template by a rigid registration to 
ensure similar orientations across subjects for visual comparison and symmetric alignment of 
the hippocampal long axes with the AP-axis. For accurate matching to the group template, 
each subject’s 3D-T1 was non-rigidly registered to the group template by first a full affine 
registration to account for scaling between different head sizes, followed by a nonlinear 
registration to account for morphological differences between subjects. Importantly, this 
nonlinear registration was optimised by only evaluating the cost-function in the registration 
in the brain excluding the hippocampal segmentations from the template; this was done to 
avoid influence of atrophy or other pathology on the registration (Figure 1c). The registrations 
were then inverted to obtain the transformation from the template to the subject’s T1 scan. 
The distance map from step 1 was then transformed to the subject’s T1. For each coronal slice 
in the subject’s hippocampal segmentation, the distances were averaged to obtain a mapping 
from the AP-location in the template to the subject’s scan (Figure 1d). Cross-sectional areas 
(CSA) – corrected for TIV – were calculated for each slice, which together with the distances 
provides a single-subject profile. 
For the T2 relaxometry, the transformation from the template to the T1 was concatenated 
with the rigid transformation from the T1 to the PD/T2 scan (Winston 2017). Similarly, the 
template distance map was transformed to obtain a mapping of location, and averaged within 
the hippocampal segmentation in the PD/T2-space. 
 
3) Normative database generation 
To generate a normative range with which to compare individual patient profiles to, all 111 
healthy volunteers’ CSA and T2 profiles were used. At steps of one millimetre along the AP-
axis, the means (μ) and standard deviations (σ) of the hippocampal CSA and qT2 were 
calculated using a kernel density estimator. These were used to generate a normative range 
(μ ± 1.96*σ) of CSA and qT2 at each point along the AP axis of the hippocampus. 
 
4) HS group averages 
To compare TLE patient groups to controls in a group-wise fashion, step 3) was repeated for 
each of the LHS, RHS, and BHS groups. 
 
5) Comparison of individual profiles 
To compare individual subject profiles to the normative database from step 3), the same 
registrations as in step 2) were used. For the CSA, which originates from a 1 mm isotropic 
scan, the subject’s profile is shown as a continuous profile to be compared to the normative 
data (μ ± 1.96*σ). For the qT2 values, calculated from a 2D acquisition with 4 mm slice 
thickness, the data points from each slice are shown. 
 
Interscan reproducibility 
To investigate scan-rescan reproducibility of the profiles, twenty controls that were scanned 
twice were processed and compared. The CSA and T2 profiles were subtracted from each 
other at each point, and the same kernel density estimation method as above was used to 
estimate the scan-rescan variability by estimating differences between in CSA and T2 values 
from the two scans at each point along the AP-axis. 
 
Statistical interpretation 
Whole hippocampal volumes and qT2s were compared using ANOVA between the four 
groups, and post-hoc t-tests between two groups if group-level differences were detected. 
Statistical comparisons were performed at each point along the AP-axis comparing the 
normative range (from the 111 control subjects) to the three patient groups. For any point 
along the AP axis, the CSA was said to be smaller if the subject profile fell below the normal 
range (i.e., CSA < μ-1.96*σ). For the T2 measurements, this was if the subject profile showed 
higher qT2 than the normal range (i.e., qT2 > μ+1.96*σ). For group comparisons, the mean 
profile of the HS subtypes was compared to the normative range. For individual comparisons, 
the percentages of individuals with an abnormal profile was calculated for each point along 




An example profile of a healthy control is shown in Figure 2, which two example cross-
sectional cuts through the hippocampal segmentation at the head and body. The closest 
corresponding slices from the T2 map are shown as well. 
 
Average hippocampal volumes were reduced ipsilaterally and qT2 values were increased 
bilaterally in the unilateral HS patients, whereas there were bilateral volume and qT2 changes 
in bilateral HS patients (Supplemental Table S2). Comparing the CSA and qT2 profiles of the 
three patient groups to the normative data shows that on average sclerotic hippocampi had 
significantly decreased CSA along a large proportion of the length (Figure 3). On a group level, 
the ipsilateral hippocampus in LHS was more atrophic than the ipsilateral hippocampus in RHS 
(Figure 3). Similarly, in BHS, the left hippocampus was more atrophic than the right. This 
asymmetry was less obvious in the qT2 values. There is a bigger portion of the sclerotic right 
hippocampus (in RHS and BHS) with increased qT2 compared to the left hippocampus (in LHS 
and BHS). 
 
From the control group, 20 subjects were scanned again for test-retest analysis of both the 
imaging protocols and the analysis methods. A comparison of the standard deviation over the 
entire control population (n=111) and the intra-subject scan-rescan variation show the same 
spatial patterns, with CSA repeatability much higher than inter-subject variation (Figure 4). 
 
Regarding whole-hippocampal volumes, the ipsilateral hippocampus was significantly 
atrophic in 29/32 (90.6%) of both LHS and RHS cases, with 4/5 (80%) and 5/5 (100%) of left 
and right hippocampi in BHS patients, respectively, atrophic. For whole-hippocampal qT2, 
ipsilateral hippocampi with significantly elevated qT2 were present in 18/32 (56.3%) LHS and 
21/32 (65.6%) RHS patients, with 3/5 (60%) of left and 5/5 (100%) of right hippocampi 
affected in BHS. Figure 5 shows example CSA and T2 profiles for one LHS and one RHS patient 
in which no whole-hippocampus abnormalities were detected. These profiles demonstrate 
the benefit of analysing volumetry and qT2 values in more detail: for instance, confirming 
borderline normal/abnormal cases and providing more specific localisation. 
 
In the patients where no radiological diagnosis of HS was made, but where resection did prove 
histopathological evidence of HS, three cases had dual pathology including HS, and two only 
HS  (Table S1). For two of these patients, the CSA and qT2 profiles were indicative of 
hippocampal abnormalities, as shown in Figure 6. For patient 4, signal alterations were 
remarked upon in radiological review but not deemed clinically significant. These alterations 
were picked up with three slices of 4 mm thickness showing significantly increased qT2 
corresponding with localised asymmetry in volume. 
 
Discussion 
In this study we presented an automated processing framework to look at localised 
hippocampal volumetry and T2 relaxometry by visualising this along the anterior-posterior 
axis. We observed group differences between LHS, RHS, and BHS with respect to a large group 
of healthy controls. These differences in cross-sectional area and qT2 are widespread and 
provide a more detailed representation of the quantitative imaging compared to single values 




There is no evidence for different patterns of atrophy between the affected hippocampi in 
those with unilateral and bilateral HS, with very similar CSA profiles in the left hippocampus 
in LHS and BHS, and the right hippocampus in RHS/BHS (Figure 3). We found that in unilateral 
HS the significantly increased qT2 in the contralateral side (Table S2; Winston  2017) is a mild 
widespread increase, thus providing further support for either drug-related or seizure-related 
changes (Jackson 1993a, Scott 2003). 
 
Spatial variability 
Previous efforts towards qT2 profiling in the hippocampus had demonstrated a spatial 
gradient with qT2 higher anterior than posterior in both controls and patients with HS 
(Woermann 1998). Our results do not show such gradients. The methodology between 
Woermann et al., and this work is significantly different, with imaging and processing 
improved over time. In our current work: 1) image resolution is higher (voxel volume 0.74 
mm3 vs. 4.40 mm3); 2) we sample the entire hippocampus rather than a small manually placed 
region; 3) we exclude any partial volume voxels (as in Winston 2017); and 4) had a bigger 
control population (111 vs. 20); all of which could potentially remove the apparent spatial 
gradient seen in Woermann et al., 1998. 
 
The widespread abnormalities observed in this work (Figure 3) are concordant with evidence 
from both histopathology and imaging research indicating abnormalities in the CA1-CA3 
subfields and dentate gyrus which run most of the length of the hippocampus (e.g., Briellman 
2002, Von Oertzen 2002, Stefanits 2017) - for comparison of the orientations of these 
subfields to the CSA profiles please see Figure S1. Using automated tools for hippocampal 
subfields segmentation (Iglesias 2015, Yushkevich 2015), group-level differences in these 
subfields are also observed (Sone 2016), but patient-specific results at 3T or 7T have so far 
remained inconclusive as to the use in either improved detection of HS or prediction of post-
operative seizure outcome (Voets 2017, Kreilkamp 2018, Shah 2019).  
Increased variability of both CSA and qT2 in the control population around the hippocampal 
head is also seen in the test-retest analyses, and could be caused by residual imperfections in 
correcting for different lengths of hippocampi. The fact that the overall scan-rescan variability 
is 25-30% of the inter-subject variation is an indication of how reproducible these CSA profiles 
are. The intra-subject and inter-subject variation in the T2 profiles is almost identical, in both 
spatial variation along the long axis as well as magnitude. The higher scan-rescan variability 
here is likely to come from different slice positions, with 4 mm slices inherently causing 
greater scan-rescan variability than the isotropic 1mm acquisition of the 3D-T1. The increased 
variability in qT2 in the hippocampal head is expected to arise from the underlying anatomy, 
where the folded structures include small layers of CSF that increase voxel-wise qT2 which 
our partial volume correction (Winston 2017) might not solve fully. 
Generalisation 
This methodology has been made publicly available online, by extending the existing 
HippoSeg web-based service (http://niftyweb.cs.ucl.ac.uk/program.php?p=HIPPOSEG) to 
include CSA profiling (Winston 2013, Prados 2016). To account for inter-scanner differences 
in acquisition protocols, we have included two publicly available MRI datasets to the online 
tool to almost triple the normative database to enhance generalisability to other centers (See 
Online Supporting Information for more details). The T2 relaxometry sequence is likely to be 
more varied with scan set-up, and the lack of use outside of dedicated epilepsy imaging 
centers means there are no available datasets online. We have therefore not included this in 
our online tool. 
 
Limitations 
One of the limitations of the used methodology arises from the inherent issue of modelling 
the T2 relaxometry as a single qT2 value per voxel. This disregards any partial volume effects, 
and increases the variability in the measurements – especially in the head of the 
hippocampus. The 4 mm thick slices increase increasing partial voluming, but was necessary 
to achieve sufficient signal-to-noise ratio for reliable qT2 quantification. 
Validation of these tools is complicated by a lack of a full ground-truth of the whole 
hippocampus. Firstly, hippocampal resections for mesial TLE typically only resect the anterior 
2 cm of the hippocampus (Galovic 2019), limiting the available histology. We therefor 
recommend the use of this methodology as an adjunct to expert radiological and neurological 
review. 
The patient selection criteria for the large cohort used in this study was based on review of 
radiological reporting, selecting confirmed or suspected HS cases. This may also have resulted 
in demonstrating the profiling method more as a tool for improved characterisation rather 
than improved diagnosis of subtle HS, even if improved sensitivity over whole-hippocampal 
quantification was demonstrated (Figure 5). 
 
Clinical utility 
The potential clinical utility of this method is three-fold. Firstly, to identify subtle, especially 
focal anterior, HS that may be overlooked by visual reading. Secondly to offer the possibility 
of a restricted hippocampal resection, sparing structurally normal hippocampal tissue that 
may be contributing usefully to memory function (Sidhu 2016). Third, to identify subtle 
bilateral HS that may not be reported on visual reading, and which may militate against 
hippocampal resection. 
 
Implications & Future work 
The presented automated subject-specific analysis has been designed to integrate into a 
quantitative imaging setup of 3D-T1 and T2 relaxometry already recommended for routine 
clinical imaging in TLE patients (Coan 2014, Bernasconi 2019). The personalised approach 
taken in this work is specifically intended to facilitate integration into patient-based clinical 
research settings, hence the visualisation approaches taken to compare profiles to a 
normative database. In this, it is different from many recent approaches designed for group-
based analyses (e.g., Goubrain 2015, Sone 2016, Yoo 2019, Hakimi 2019, Costa 2019). We 
suggest that this method may increase sensitivity, specificity, and/or localisation (as indicated 
in Figures 5 and 6) when used in radiological reporting or epilepsy surgery multi-disciplinary 
team discussions. Further evaluation in other patient populations is now warranted. 
 
Conclusions 
Localised volumetry and relaxometry measures of the hippocampus are possible to extract in 
a reliable and reproducible manner. CSA profiling is freely available online for widespread use.  
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Figure 1: a) The MNI-152 template is reoriented so that the hippocampi are along the A-P axis 
(realigned MRI, rMRI). b) All healthy controls were registered to this in a groupwise way to 
generate a group template image. c) A brain mask (yellow) excluding the hippocampi is 
generated for the group template to drive the non-linear registration between template and 
subject (d). The distance map (c) from the template is resampled to the subject space (d) and 
evaluated at each slice within the hippocampal segmentations, red volumes in (d). 
 
Figure 2: A raw 3D-T1 image of a healthy control with hippocampal segmentations is shown 
in the top row, in a sagittal (left panel) and axial (right panel) view. After rigid rotation to the 
group template (second row) the hippocampal long axis is along the posterior-anterior (P-A) 
axis. The cross-sectional area (CSA) and T2 profiles are shown in the third row in a black line 
and black crosses, respectively, over the normative range (blue shaded area). The two red 
arrows indicate cuts through the hippocampus at the body (solid arrowhead) and the head 
(open arrowhead), as shown in the bottom row (T1 left, T2-map right). 
 
Figure 3: Average cross-sectional area (CSA, top row) and T2 (bottom row) profiles per subject 
group. The blue dashed line is the average of the healthy controls, and the blue shaded area 
around that the normative range from these controls. The average profiles for each of the 
three patient groups (LHS in red, RHS in black, and BHS in green) show decreased CSA along 
much of the length of the hippocamps. The asterisks indicate that at that point the patient 
profile was below the normative range of the controls (μ ± 1.96σ). 
 
Figure 4: Comparisons of intersubject variability (population-based standard deviation) in CSA 
(top row) and T2 (bottom row) compared to intrasubject variability (scan-rescan) along the 
length of the hippocampus in twenty controls.  
 
Figure 5: Example profiles of radiologically-defined unilateral HS without volume or qT2 
abnormalities on the whole-hippocampal level. 
a) Patient with left HS, had a hippocampal volume just within the normative range (2.40 / 
2.84 ml ipsi/contralateral, control range 2.40-3.39 ml) and normal qT2 (112.8 / 116.4 ms 
ipsi/contralateral, control range 108.5-123.8 ms). CSA and T2 profiles show a clear volume 
asymmetry primarily anteriorly. 
b) Patient 2 with right HS who had normal volumes (2.41 / 3.29 ml ipsi/contralateral, control 
range 2.40-3.39 ml) and qT2 (118.9 / 112.2 ms ipsi/contralateral, control range 108.5-123.8 
ms). CSA and T2 profiles show a clear anterior abnormality in both the CSA and T2 plots. 
 
Figure 6: Examples cases without radiological diagnosis of HS but with HS on histopathology. 
a) Patient 2 from Table S1, with left TLE and normal hippocampal volumes (2.52 / 2.93 ml for 
ipsi/contralateral, control range 2.40-3.39 ml) and qT2 (116.3 / 117.1 ms for 
ipsi/contralateral, control range 108.5-123.8 ms). The CSA profiles show asymmetry along a 
big proportion of the length of the hippocampus, with significantly smaller CSA along part of 
the head and body of the hippocampus. No qT2 abnormalities observed anywhere along the 
profile. b) Patient 4 from Table S1 with left TLE and normal hippocampal volumes (2.69 / 3.01 
ml for ipsi/contralateral, control range 2.40-3.39 ml) and qT2 (123.5 / 115.1 ms for 
ipsi/contralateral, control range 108.5-123.8 ms). CSA profiles show slightly larger than 
normal volumes along the head and body of the hippocampus, with asymmetry along the 
body with predominantly lower cross-sectional area in the ipsilateral, left, hippocampus. This 













Hippocampal subfield segmentation 
The healthy control shown in Fig. 2 was processed with FreeSurfer v6.0.0 using the automated 
hippocampal segmentation method (Iglesias et al., 2015) and aligned with the template image 
to visualise the association of the subfields with the hippocampal CSA profiles (Fig. S1).  
 
Generalisation  
For generalisability to an online tool, we included two publicly available 3T imaging datasets: 
Alzheimer’s Disease Neuroimaging Initiative (ADNI) and Track-HD (Tabrizi et al., 2012). TRACK-
HD T1-weighted image volumes were acquired using a 3D MPRAGE acquisition sequence on 
3.0 T Siemens and Phillips scanners with a voxel size of 1.10×1.10×1.10 (Philips) and 
1.07×1.07×1.10 (Siemens). This included a total of 98 subjects (age μ±σ 46.6±10.7, range 23.0-
65.7 years; 43M/55F). The 3T ADNI data were acquired at multiple scanners and scans were 
only excluded for image quality reasons. Voxel size for these 3D MPRAGE/IR-FSPGR 
acquisition varied between 1.00×1.00×1.20 to 1.05×1.05×1.20 mm (see 
http://adni.loni.usc.edu/methods/documents/mri-protocols/ for imaging details), leading to 
a total of 217 subjects. To match sample sizes to the Chalfont and Track-HD populations, 109 
randomly selected subjects were taken (age μ±σ 73.7±5.7, range 59.9-86.0 years; 50M/59F).   
 
The methodology of processing these additional datasets was identical to the main 
manuscript. Fig. S2 shows the comparison of the normative ranges for both left and right 
hippocampi in individual plots. Fig. S3 shows the averages and standard deviations of the 
three populations in a single plot. Comparing the three datasets, the mean CSA along the 
hippocampal long axis varies very little despite the generally higher age in the ADNI database 
(Fig. S3a,b). Similarly, the same regions of increased variability are seen (Fig. S3c,d) and little 
difference in the magnitude of variation. As a result, we feel justified in combining all three 
of these populations. 
 
 
Supplementary Table S1: Details of patients without HS as radiological diagnosis 




Radiological diagnosis Pathological 
report 
Patient 1 (F) 27.0 y 27.4 y R amyg lesion – DNT? 
DNT (GG,GR 1), 
HS (EFS) 
Patient 2 (F) 28.1 y 28.8 y L amyg lesion – DNT? 
DNT (GNT), HS 
type 1 
Patient 3 (F) 48.2 y 48.4 y 
Subtle increase in T2 signal in R 
amyg and hippocampal head 
HS type 2 
Patient 4 (F) 37.6 y 37.7 y 
L hippocampal bowel 
asymmetry, no convincing signal 
alteration 
HS type 1 
Patient 5 (M) 60.8 y 62.3 y 
Cavernoma abutting left 
temporal horn 
Cavernoma, 
mild HS type 3 
HS = hippocampal sclerosis ; F = female, m = male; R = right; L = left; Amyg = amygdala; DNT 





Supplementary Table S2: Volume and qT2 of whole hippocampi 
 HC (n=111) LHS (n=32) RHS (n=32) BHS (n=5) 
Left volume (ml) 2.87 ± 0.26 1.92 ± 0.35* 2.83 ± 0.21 1.95 ± 0.23* 
Right volume (ml) 2.92 ± 0.25 2.82 ± 0.29 2.07 ± 0.28* 2.14 ± 0.31* 
Left qT2 (ms) 112.7 ± 11.4 125.1 ± 6.9* 115.9 ± 4.7^ 124.6 ± 7.3* 
Right qT2 (ms) 113.4 ± 11.5 117.8 ± 3.1* 126.0 ± 6.2* 127.7 ± 3.5* 
HC = healthy controls; LHS = left HS; RHS = right HS; BHS = bilateral HS; qT2 = quantitative T2; 




Supplementary figure legends 
Figure S1: A sagittal slice through the left hippocampus (a), with the subfields colour-coded 
(b), and the associated cross-sectional area (CSA) profile (c). The subfield colours are: 
CA1=red, CA2=, CA3=green, CA4=brown, molecular layer=maroon, dentate gyrus=aqua, 
presubiculum=dark purple, subiculum=dark blue, tail=light purple. 
 
Figure S2: Mean and normative ranges shown for cross-sectional area (CSA) plot from three 
different healthy control cohorts: a local Chalfont one, from the Track-HD study, and from 
ADNI. 
 
Figure S3: The normative range (blue shaded area) of the entire healthy control population 
from the three different cohorts, with the mean shown as a dashed blue line, for the CSA of 
the left (a) and right (b) hippocampus. The mean CSA profiles for the three cohorts are shown: 
local cohort (solid green line), ADNI (red dashed-dotted line), and Track-HD (black dotted 
line). Panels c and d show the standard deviations along the PA-axis, with the same colour-
encoding per line. 
